Dysautonomia is far more common than most people realize. When you add up every form of autonomic nervous system dysfunction, from the mildest to the most severe, tens of millions of people in the United States alone are affected. The reason it flies under the radar is that “dysautonomia” is an umbrella term covering a wide range of conditions, some extraordinarily common and others genuinely rare.
The Most Common Form Affects Roughly 1 in 3 Adults
Vasovagal syncope, the classic “fainting spell,” is the single most common type of dysautonomia. A systematic review and meta-analysis found an average prevalence of about 22% in the general population. Roughly 35% of people between ages 35 and 60 have fainted at least once from a vasovagal episode. By age 60, that number climbs to 42% of women and 32% of men. Most people who faint once or twice never think of it as a medical condition, but it is a form of autonomic dysfunction where the nervous system briefly misfires, dropping heart rate and blood pressure at the same time.
For many people, vasovagal syncope is a one-time event triggered by heat, standing too long, or the sight of blood. For others, it becomes a recurring problem that limits daily life. Recurrent vasovagal syncope sits on a spectrum between a minor nuisance and a disabling condition, depending on frequency and severity.
POTS Affects 1 to 3 Million Americans
Postural orthostatic tachycardia syndrome, or POTS, is probably what most people picture when they hear “dysautonomia.” It causes the heart rate to spike excessively upon standing, along with dizziness, fatigue, brain fog, and sometimes fainting. Estimates from Dysautonomia International and Johns Hopkins Medicine put the number at one to three million people in the U.S.
POTS overwhelmingly affects women. In patient cohort studies, females represent roughly 90% of diagnosed cases. It most commonly develops during adolescence and young adulthood, often around puberty, though it can appear at any age. Men do develop POTS, but at significantly lower rates. The condition is less common in young children, with adolescents showing higher rates of autonomic dysregulation than younger kids.
COVID-19 Added Millions of Cases Worldwide
The pandemic dramatically expanded the number of people living with dysautonomia. About 2.5% of people who develop long COVID experience autonomic dysfunction afterward, which translates to an estimated 2 to 6.5 million people worldwide. Among patients with more severe long COVID (those who were hospitalized or had life-limiting symptoms beyond 12 weeks), the rate jumps to roughly 25%.
Post-COVID dysautonomia typically looks similar to POTS or other forms of autonomic dysfunction triggered by viral infections. The symptoms, including racing heart on standing, exercise intolerance, and blood pressure instability, are clinically indistinguishable from dysautonomia caused by other triggers. This wave of new cases has been one of the main reasons awareness of dysautonomia has grown in recent years.
Diabetes Is the Leading Cause of Secondary Dysautonomia
Diabetic autonomic neuropathy is one of the most widespread forms of dysautonomia globally, though it’s rarely discussed in those terms. Nerve damage from chronically elevated blood sugar gradually impairs the autonomic nervous system, affecting heart rate control, digestion, bladder function, and blood pressure regulation.
About 7% of people with type 1 or type 2 diabetes already have measurable autonomic nerve damage at the time of diagnosis. The risk increases by roughly 6% per year in type 1 diabetes and 2% per year in type 2. After 15 years with diabetes, up to 50 to 60% of patients develop significant autonomic neuropathy. Given that more than 38 million Americans have diabetes, this represents millions of people with a form of dysautonomia that often goes unrecognized as such.
Dysautonomia in Hypermobility Disorders
People with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders have strikingly high rates of autonomic dysfunction. In a study of 144 patients with these conditions, 65% of women and 44% of men met criteria for dysautonomia. The most common complaint was exercise intolerance, affecting 78% of those with autonomic involvement.
The impact on daily function was dramatic. Before their hypermobility symptoms flared, 44% of dysautonomic patients in the study were sedentary. After symptom onset, that proportion rose to 85%. This connection between joint hypermobility and autonomic dysfunction is well established, and many POTS specialists now routinely screen for hypermobility in their patients.
Rare Forms: Multiple System Atrophy
Not all dysautonomia is common. Multiple system atrophy (MSA), a progressive neurodegenerative condition that severely disrupts autonomic function along with movement and balance, affects only about 2 to 5 people per 100,000. Unlike POTS, it strikes men and women equally and typically begins around age 56. Pure autonomic failure, another rare degenerative form, is even less well studied and appears to be similarly uncommon, though firm prevalence numbers are limited.
These rare forms are far more severe than POTS or vasovagal syncope. MSA in particular progresses steadily and has no cure, making early recognition important even though the condition itself is uncommon.
Why Dysautonomia Seems Rarer Than It Is
The biggest reason dysautonomia appears uncommon is that it’s underdiagnosed. A study published in the Journal of Patient Experience found that dysautonomia patients, who are overwhelmingly female with a median age of 41, often face long delays between the start of symptoms and receiving a diagnosis. The symptoms (dizziness, fatigue, rapid heart rate, digestive problems) overlap with dozens of other conditions, and many primary care providers aren’t trained to recognize autonomic dysfunction.
The numbers also fragment across specialties. A cardiologist may diagnose POTS, a neurologist may identify autonomic neuropathy, and a gastroenterologist may diagnose gastroparesis, all without anyone connecting these under the dysautonomia umbrella. When researchers try to estimate total prevalence, they’re often counting each subtype separately rather than capturing the full scope of autonomic disorders.
If you combine the one to three million Americans with POTS, the millions more with diabetic autonomic neuropathy, the post-COVID cases, and the tens of millions who have experienced vasovagal syncope, dysautonomia in its various forms is one of the most common categories of neurological dysfunction. It just hasn’t been treated that way by the medical system.